Both in Pharmaceuticals
Phathom Pharmaceuticals vs Aquestive Therapeutics
Over the past year PHAT returned −57.9% and AQST returned −37.5%; their daily moves had a correlation of 0.19.
PHAT −57.9% AQST −37.5%Growth of $1, one year, split-adjusted
| Metric | PHAT | AQST |
|---|---|---|
| Price | $5.68 | $3.80 |
| Market cap | $461.7M | $476.9M |
| Today | −1.05% | −2.06% |
| 1 month | −16.2% | −17.6% |
| 6 months | −55.2% | −10.2% |
| Year to date | −65.8% | −41.2% |
| 1 year | −58.6% | −41.4% |
| Revenue growth (YoY) | +71.1% | +38.1% |
| Gross margin | 78.3% | 70.9% |
| Net margin | −16.4% | −165.5% |
| P/E (TTM) | — | — |
| Price / sales | 1.7× | 8.8× |
| Net cash | $17.6M | $47.8M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | 54.2% |
| Short % of float | 17.5% | 25.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).